Medika Natura Overview
- Year Founded
-
2006
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
Medika Natura General Information
Description
Operator of a biopharmaceutical therapeutics company intended to provide botanical drugs. The company specializes in the development, production, and commercialization of botanical bio-active compounds for the treatment of obesity, diabetes, cancer, and COVID-19, helping patients tackle metabolic syndrome diseases.
Contact Information
Website
www.medikanatura.comCorporate Office
- Number 44B, Jalan Bola Tampar, 13/14
- Seksyen 13
- Shah Alam, Selangor
- Malaysia
Corporate Office
- Number 44B, Jalan Bola Tampar, 13/14
- Seksyen 13
- Shah Alam, Selangor
- Malaysia
Medika Natura Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Dec-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 19-Feb-2020 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jan-2008 | Completed | Generating Revenue |
Medika Natura Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Medika Natura Patents
Medika Natura Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4426326-A1 | Labisia pumila extract composition and its pharmaceutical formulation | Pending | 02-Nov-2021 | ||
| US-12403166-B2 | Labisia pumila extract composition and its pharmaceutical formulation | Active | 02-Nov-2021 | ||
| US-20230134529-A1 | Labisia pumila extract composition and its pharmaceutical formulation | Active | 02-Nov-2021 | ||
| US-20250288629-A1 | Labisia pumila extract composition and its pharmaceutical formulation | Pending | 02-Nov-2021 | ||
| WO-2023080772-A1 | Labisia pumila extract composition and its pharmaceutical formulation | Inactive | 02-Nov-2021 | A61K36/185 |
Medika Natura Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cradle Fund | Accelerator/Incubator | Minority | ||
| Malaysian Technology Development Corporation | Venture Capital | Minority | ||
| RIO Ventures Holdings | Venture Capital | Minority | ||
| Malaysian Bioeconomy Development Corporation | Other | Minority |
Medika Natura FAQs
-
When was Medika Natura founded?
Medika Natura was founded in 2006.
-
Where is Medika Natura headquartered?
Medika Natura is headquartered in Shah Alam, Malaysia.
-
What industry is Medika Natura in?
Medika Natura’s primary industry is Drug Discovery.
-
Is Medika Natura a private or public company?
Medika Natura is a Private company.
-
What is Medika Natura’s current revenue?
The current revenue for Medika Natura is .
-
How much funding has Medika Natura raised over time?
Medika Natura has raised $26.5K.
-
Who are Medika Natura’s investors?
Cradle Fund, Malaysian Technology Development Corporation, RIO Ventures Holdings, and Malaysian Bioeconomy Development Corporation have invested in Medika Natura.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process